These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 26897037)

  • 1. Metabonomic biomarkers for risk factors of chronic kidney disease.
    Ye L; Mao W
    Int Urol Nephrol; 2016 Apr; 48(4):547-52. PubMed ID: 26897037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic kidney disease: Biomarker diagnosis to therapeutic targets.
    Wang YN; Ma SX; Chen YY; Chen L; Liu BL; Liu QQ; Zhao YY
    Clin Chim Acta; 2019 Dec; 499():54-63. PubMed ID: 31476302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biomarkers in Chronic Kidney Disease].
    Munguía-Miranda C; Paniagua-Sierra JR
    Rev Med Inst Mex Seguro Soc; 2017; 55(Suppl 2):S143-50. PubMed ID: 29697235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomic Signatures of Chronic Kidney Disease of Diverse Etiologies in the Rats and Humans.
    Zhang ZH; Chen H; Vaziri ND; Mao JR; Zhang L; Bai X; Zhao YY
    J Proteome Res; 2016 Oct; 15(10):3802-3812. PubMed ID: 27636000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic Kidney Disease and the Search for New Biomarkers for Early Diagnosis.
    Saucedo AL; Perales-Quintana MM; Paniagua-Vega D; Sanchez-Martinez C; Cordero-Perez P; Minsky NW
    Curr Med Chem; 2018; 25(31):3719-3747. PubMed ID: 29521201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolomics insights into activated redox signaling and lipid metabolism dysfunction in chronic kidney disease progression.
    Chen H; Cao G; Chen DQ; Wang M; Vaziri ND; Zhang ZH; Mao JR; Bai X; Zhao YY
    Redox Biol; 2016 Dec; 10():168-178. PubMed ID: 27750081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic clinical and molecular biomarkers of renal disease in type 2 diabetes.
    Pena MJ; de Zeeuw D; Mischak H; Jankowski J; Oberbauer R; Woloszczuk W; Benner J; Dallmann G; Mayer B; Mayer G; Rossing P; Lambers Heerspink HJ
    Nephrol Dial Transplant; 2015 Aug; 30 Suppl 4():iv86-95. PubMed ID: 26209743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. You Are What You Eat: Metabolites of Gut Microbiota Provide Novel Insights into Diagnosis and Development of Chronic Kidney Disease.
    Quante M
    Transplantation; 2015 Jul; 99(7):1306-7. PubMed ID: 26147133
    [No Abstract]   [Full Text] [Related]  

  • 9. Biomarkers of obstructive nephropathy using a metabolomics approach in rat.
    Zhang ZH; He JQ; Qin WW; Zhao YY; Tan NH
    Chem Biol Interact; 2018 Dec; 296():229-239. PubMed ID: 30339777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute Kidney Injury: Tubular Markers and Risk for Chronic Kidney Disease and End-Stage Kidney Failure.
    Tan HL; Yap JQ; Qian Q
    Blood Purif; 2016; 41(1-3):144-50. PubMed ID: 26764483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic biomarkers for chronic kidney disease.
    Breit M; Weinberger KM
    Arch Biochem Biophys; 2016 Jan; 589():62-80. PubMed ID: 26235490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomics and renal disease.
    Rhee EP
    Curr Opin Nephrol Hypertens; 2015 Jul; 24(4):371-9. PubMed ID: 26050125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UPLC-based metabonomic applications for discovering biomarkers of diseases in clinical chemistry.
    Zhao YY; Cheng XL; Vaziri ND; Liu S; Lin RC
    Clin Biochem; 2014 Oct; 47(15):16-26. PubMed ID: 25087975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers of renal function, which and when?
    Wasung ME; Chawla LS; Madero M
    Clin Chim Acta; 2015 Jan; 438():350-7. PubMed ID: 25195004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomics in chronic kidney disease.
    Zhao YY
    Clin Chim Acta; 2013 Jun; 422():59-69. PubMed ID: 23570820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation-Related Mechanisms in Chronic Kidney Disease Prediction, Progression, and Outcome.
    Mihai S; Codrici E; Popescu ID; Enciu AM; Albulescu L; Necula LG; Mambet C; Anton G; Tanase C
    J Immunol Res; 2018; 2018():2180373. PubMed ID: 30271792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers in acute and chronic kidney disease.
    Nickolas TL; Barasch J; Devarajan P
    Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):127-32. PubMed ID: 18277143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMR-based metabolomics associated with chronic kidney disease in humans and animals: a one health perspective.
    Hunter E; Percival B; Ahmad Z; Chang MW; Hunt JA; Tasker S; De Risio L; Wilson PB
    Mol Cell Biochem; 2021 Nov; 476(11):4133-4137. PubMed ID: 34312783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A metabolomics-based approach for predicting stages of chronic kidney disease.
    Kobayashi T; Yoshida T; Fujisawa T; Matsumura Y; Ozawa T; Yanai H; Iwasawa A; Kamachi T; Fujiwara K; Kohno M; Tanaka N
    Biochem Biophys Res Commun; 2014 Mar; 445(2):412-6. PubMed ID: 24530913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update of urine and blood metabolomics in chronic kidney disease.
    Kalantari S; Nafar M
    Biomark Med; 2019 May; 13(7):577-597. PubMed ID: 31140832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.